John W. Cumming's Insider Trades & SAST Disclosures
John W. Cumming's most recent trade in Texas Capital Bancshares, Inc. was a trade of 1,469 Common Stock done . Disclosure was reported to the exchange on Feb. 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John W. Cumming.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 1,469 | 8,179 (0%) | 0% | 0 | Common Stock | |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 1,469 | 2,940 | - | - | 2024 Restricted Stock Units | |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.02 per share. | 14 Feb 2025 | 358 | 7,821 (0%) | 0% | 81.0 | 29,005 | Common Stock |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 1,306 | 7,027 (0%) | 0% | 0 | Common Stock | |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 1,306 | 1,307 | - | - | Restricted Stock Units | |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.00 per share. | 07 Feb 2025 | 317 | 6,710 (0%) | 0% | 83 | 26,311 | Common Stock |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 1,725 | 6,233 (0%) | 0% | 0 | Common Stock | |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 1,725 | 0 | - | - | Restricted Stock Units | |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.23 per share. | 03 Feb 2025 | 512 | 5,721 (0%) | 0% | 77.2 | 39,542 | Common Stock |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 4,497 | 4,497 | - | - | 2025 Restricted Stock Units | |
| T2 Biosystems Inc | John Cumming W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| Texas Capital Bancshares, ... | John W. Cummings | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 5,320 | 5,320 | - | - | 2024 Restricted Stock Units | |
| T2 Biosystems Inc | John W. Cumming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2022 | 130,000 | 130,000 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | John W. Cumming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 81,967 | 132,819 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | John W. Cumming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 81,967 | 0 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | John W. Cumming | Director | Sale of securities on an exchange or to another person at price $ 1.16 per share. | 01 Jul 2021 | 18,182 | 50,852 (0%) | 0% | 1.2 | 21,091 | Common Stock |
| T2 Biosystems Inc | John W. Cumming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 81,967 | 81,967 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | John W. Cumming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 45,454 | 69,034 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | John W. Cumming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 45,454 | 45,454 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | John W. Cumming | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 45,454 | 45,454 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges